Learning Objectives
- Describe the inheritance patterns and complications of α and ß thalassaemia and sickle cell anaemia.
- Indications of transfusion and complications of long-term transfusion.
- Understand the indications for starting iron-chelating agents
- Prescribe prophylactic folate and where appropriate.
- Understand the role of genetic counselling and prenatal diagnosis for congenital haemolytic anaemia disorders.
Please click here if you need to do some reading before attempting the quiz.
Quiz Summary
0 of 9 Questions completed
Questions:
Information
You must fill out this field. |
|
You must fill out this field. |
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 9 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Average score |
|
Your score |
|
Categories
- Not categorized 0%
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- Current
- Review
- Answered
- Correct
- Incorrect
-
Question 1 of 9
1. Question
1 point(s)A 28-year-old lady presents with a first pregnancy. She has recently emigrated to this country from India and has no medical records. She is unaware of any pre-existing illnesses and has not been transfused before. By her last menstrual period, she is 12 weeks pregnant. On examination, there is conjunctival pallor and mild hepatosplenomegaly. Booking scans are organised. Initial investigations reveal:
Haemoglobin 8.2 g/dL (11.4-14.7)
MCV 58fL (83.0-95.5)
RBC 4.56×1012/L (4.00-5.20)
RDW 14.0% (10.9-14.3)
Platelets 428×109/L (164-387)
WBC 7.8×109/L (3.84-10.01)Iron 37.2µmol/L (9.5-30.0)
Ferritin 1513 µg/L (20-300)
Transferrin 218 mg/dL (200-360)
TIBC 57% µmol/L (52-94)
Iron saturation 66% (20-50)HbA 90% (96.8-98.3)
HbA2 4.0% (1.7-3.2)
HbF 6.0% (0.0-1.0)What is the most likely underlying diagnosis?
CorrectIncorrect -
Question 2 of 9
2. Question
1 point(s)Why is her ferritin raised?
CorrectIncorrect -
Question 3 of 9
3. Question
1 point(s)The patient is surprised to learn that she has β thalassaemia intermedia. She asks what the chance of her baby being affected is.
Based on the clinical information provided above, what is her likely genotype?
CorrectIncorrect -
Question 4 of 9
4. Question
1 point(s)You ask to screen the baby’s father. His investigations are shown below:
Haemoglobin 11.1 g/dL (13.1-16.6)
MCV 71fL (83.0-95.5)
RBC 5.87×1012/L (4.00-5.20)
RDW 14.2% (10.9-14.3)
Platelets 365×109/L (164-387)
WBC 5.4×109/L (3.84-10.01)HbA 95% (96.8-98.3)
HbA2 4.5% (1.7-3.2)
HbF 0.5% (0.0-1.0)Based on the most likely paternal genotype, how would you counsel the patient?
CorrectIncorrect -
Question 5 of 9
5. Question
1 point(s)She is offered pre-natal diagnosis, which she declines. Her pregnancy proceeds uneventfully, and she delivers a baby. She would like to know if the baby is affected by β thalassaemia.
How would you counsel the patient?
CorrectIncorrect -
Question 6 of 9
6. Question
1 point(s)A year after delivery, the patient attends for a routine health check-up. Investigations as shown below:
Haemoglobin 8.2 g/dL (11.4-14.7)
MCV 58fL (83.0-95.5)
RBC 4.56×1012/L (4.00-5.20)
RDW 14.0% (10.9-14.3)
Platelets 428×109/L (164-387)
WBC 7.8×109/L (3.84-10.01)HbA1c 8.5% (4.0-5.5%)
Albumin 31g/L (38-48)
Bilirubin, total 48µmol/L (5-30)
Bilirubin, conjugated 22µmol/L (0-5)
Bilirubin, unconjugated 26µmol/L (5-25)
AST 335U/L (10-50)
ALT 562U/L (10-70)
ALP 120U/L (40-130)
LDH 560U/L (250-580)How would you investigate her abnormal liver function tests?
CorrectIncorrect -
Question 7 of 9
7. Question
1 point(s)The patient has significant liver iron loading.
How would you manage her?
CorrectIncorrect -
Question 8 of 9
8. Question
1 point(s)Due to financial constraints, the patient is started on deferiprone. A few weeks later, she attends a regular follow-up visit with a fever and sore throat.
What is the most important investigation to order?
CorrectIncorrectHint
What are the adverse effects of deferriprone? The FDA carries a black box warning for this.
-
Question 9 of 9
9. Question
1 point(s)Deferiprone is stopped and the patient is started on deferoxamine. She remains well with improvement in her liver function tests. A few years later, she presents with fever.
Haemoglobin 5.1 g/dL (11.4-14.7)
MCV 56fL (83.0-95.5)
RBC 2.56×1012/L (4.00-5.20)
RDW 13.8% (10.9-14.3)
Platelets 367×109/L (164-387)
WBC 6.4×109/L (3.84-10.01)Reticulocyte count: 0.1% (0.5-2.5%)
What is the most likely diagnosis?
CorrectIncorrectHint
This may cause a “slapped cheek”appearance in children.